Advertisement for the post of PRN III for Post-operative intraperitoneal chemotherapy after interval cytoreduction in epithelial ovarian cancer (POICE 2024): multicenter, randomized, Phase III Trial.
- Detailed Advertisement Notice Download (1018.52 KB)
- Application format Download (190.13 KB)
- CORRIGENDUM Download (462.85 KB)